BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 30814510)

  • 1. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
    Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
    Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoids: Avatars for Personalized Medicine.
    Clevers HC
    Keio J Med; 2019; 68(4):95. PubMed ID: 31875622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell-derived organoids and their application for medical research and patient treatment.
    Bartfeld S; Clevers H
    J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of organoids for personalized medicine.
    Perkhofer L; Frappart PO; Müller M; Kleger A
    Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoids for Drug Discovery and Personalized Medicine.
    Takahashi T
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():447-462. PubMed ID: 30113875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of organoids in urological cancer research.
    Wang S; Gao D; Chen Y
    Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What gastroenterologists and hepatologists should know about organoids in 2019.
    Günther C; Brevini T; Sampaziotis F; Neurath MF
    Dig Liver Dis; 2019 Jun; 51(6):753-760. PubMed ID: 30948332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome engineering of stem cell organoids for disease modeling.
    Sun Y; Ding Q
    Protein Cell; 2017 May; 8(5):315-327. PubMed ID: 28102490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational applications of adult stem cell-derived organoids.
    Drost J; Clevers H
    Development; 2017 Mar; 144(6):968-975. PubMed ID: 28292843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Organoids: A Translational Journey.
    Morizane R; Bonventre JV
    Trends Mol Med; 2017 Mar; 23(3):246-263. PubMed ID: 28188103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoid technology and applications in cancer research.
    Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
    J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney organoids in translational medicine: Disease modeling and regenerative medicine.
    Miyoshi T; Hiratsuka K; Saiz EG; Morizane R
    Dev Dyn; 2020 Jan; 249(1):34-45. PubMed ID: 30843293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications.
    Chuah JKC; Zink D
    Biotechnol Adv; 2017; 35(2):150-167. PubMed ID: 28017905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of developing human 3D organoids into medicines.
    Vives J; Batlle-Morera L
    Stem Cell Res Ther; 2020 Mar; 11(1):72. PubMed ID: 32127036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commercialization of Organoids.
    Choudhury D; Ashok A; Naing MW
    Trends Mol Med; 2020 Mar; 26(3):245-249. PubMed ID: 31982341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
    Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
    OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine.
    Lee H; Son MY
    Int J Stem Cells; 2021 Feb; 14(1):9-20. PubMed ID: 33632980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of patient-derived cancer organoids for drug-screening applications.
    Driehuis E; Kretzschmar K; Clevers H
    Nat Protoc; 2020 Oct; 15(10):3380-3409. PubMed ID: 32929210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine.
    Harris AR; Walker MJ; Gilbert F
    BMC Med; 2022 Dec; 20(1):499. PubMed ID: 36575403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.